Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.59 USD | +1.51% | -2.38% | +3.46% |
05-15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
05-14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.46% | 460M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+40.01% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Oppenheimer Adjusts Frequency Therapeutics Price Target to $8 From $14, Maintains Outperform Rating